author-photo

Gordon Cook

University of Leeds
St James's University Hospital
Leeds Teaching Hospitals NHS Trust

213

Papers

3743

Citations

Citation Trend

Filter By

Papers (213) Sort By

JournalConferenceOthers

Response to COVID-19 Vaccines in Patients Receiving Intensified Post-ASCT Therapy with Daratumumab, Lenalidomide, Bortezomib (Dara-VR) Due to Ultra-High Risk (UHiR) Newly Diagnosed Myeloma (NDMM) or Primary Plasma Cell Leukemia (pPCL): Exploratory Analysis of the UK Optimum/Muknine Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (10)
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

2021 Elements
Show All
- Source
- Cite
- Save
Citations (0)
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma

2021 CHI | Human Factors in Computing Systems
Show All
- Source
- Cite
- Save
Citations (0)
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network.

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

2021 PLOS Medicine
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号